Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.550
-0.040 (-1.11%)
Jan 13, 2026, 11:26 AM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 96.77 million as of January 13, 2026. Its market cap has increased by 95.62% in one year.
Market Cap
96.77M
Enterprise Value
149.44M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.55
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 96.77M, a decrease of -85.52%. That is a compound annual growth rate of -32.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 95.69M | 8.23% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.55B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 2.06B |
| Thor Medical ASA | 1.81B |
| ArcticZymes Technologies ASA | 1.22B |
| Omda AS | 963.86M |
| Vistin Pharma ASA | 922.37M |
| Gentian Diagnostics ASA | 909.92M |